148 related articles for article (PubMed ID: 31289348)
1. VPS35 regulates tau phosphorylation and neuropathology in tauopathy.
Vagnozzi AN; Li JG; Chiu J; Razmpour R; Warfield R; Ramirez SH; Praticò D
Mol Psychiatry; 2021 Nov; 26(11):6992-7005. PubMed ID: 31289348
[TBL] [Abstract][Full Text] [Related]
2. Full recovery of the Alzheimer's disease phenotype by gain of function of vacuolar protein sorting 35.
Li JG; Chiu J; Praticò D
Mol Psychiatry; 2020 Oct; 25(10):2630-2640. PubMed ID: 30733594
[TBL] [Abstract][Full Text] [Related]
3. VPS35 Downregulation Alters Degradation Pathways in Neuronal Cells.
Filippone A; Li JG; Praticò D
J Alzheimers Dis; 2021; 84(3):1079-1089. PubMed ID: 34602481
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease-linked
Chen X; Kordich JK; Williams ET; Levine N; Cole-Strauss A; Marshall L; Labrie V; Ma J; Lipton JW; Moore DJ
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5765-5774. PubMed ID: 30842285
[TBL] [Abstract][Full Text] [Related]
5. A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles.
Li JG; Chiu J; Ramanjulu M; Blass BE; Praticò D
Mol Neurodegener; 2020 Jan; 15(1):1. PubMed ID: 31964406
[TBL] [Abstract][Full Text] [Related]
6. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
Vagnozzi AN; Giannopoulos PF; Praticò D
Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
[TBL] [Abstract][Full Text] [Related]
7. Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells.
Gao L; Xiao H; Ai LQ; Chen C; Lin S; Zhou Y; Ye J; Liu W
Invest Ophthalmol Vis Sci; 2020 Jan; 61(1):1. PubMed ID: 31995153
[TBL] [Abstract][Full Text] [Related]
8. Reduced retromer function results in the accumulation of amyloid-beta oligomers.
Ansell-Schultz A; Reyes JF; Samuelsson M; Hallbeck M
Mol Cell Neurosci; 2018 Dec; 93():18-26. PubMed ID: 30257187
[TBL] [Abstract][Full Text] [Related]
9. The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer's disease.
Qureshi YH; Berman DE; Marsh SE; Klein RL; Patel VM; Simoes S; Kannan S; Petsko GA; Stevens B; Small SA
Cell Rep; 2022 Jan; 38(3):110262. PubMed ID: 35045281
[TBL] [Abstract][Full Text] [Related]
10. Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.
Williams ET; Chen X; Otero PA; Moore DJ
Neurobiol Dis; 2022 Aug; 170():105768. PubMed ID: 35588987
[TBL] [Abstract][Full Text] [Related]
11. Microglial VPS35 deficiency impairs Aβ phagocytosis and Aβ-induced disease-associated microglia, and enhances Aβ associated pathology.
Ren X; Yao L; Wang Y; Mei L; Xiong WC
J Neuroinflammation; 2022 Mar; 19(1):61. PubMed ID: 35236374
[TBL] [Abstract][Full Text] [Related]
12. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
13. Vps35-dependent recycling of Trem2 regulates microglial function.
Yin J; Liu X; He Q; Zhou L; Yuan Z; Zhao S
Traffic; 2016 Dec; 17(12):1286-1296. PubMed ID: 27717139
[TBL] [Abstract][Full Text] [Related]
14. Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model.
Seino Y; Kawarabayashi T; Wakasaya Y; Watanabe M; Takamura A; Yamamoto-Watanabe Y; Kurata T; Abe K; Ikeda M; Westaway D; Murakami T; Hyslop PS; Matsubara E; Shoji M
J Neurosci Res; 2010 Dec; 88(16):3547-54. PubMed ID: 20936700
[TBL] [Abstract][Full Text] [Related]
15. Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting.
Williams ET; Glauser L; Tsika E; Jiang H; Islam S; Moore DJ
Hum Mol Genet; 2018 Sep; 27(18):3189-3205. PubMed ID: 29893854
[TBL] [Abstract][Full Text] [Related]
16. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N.
Munsie LN; Milnerwood AJ; Seibler P; Beccano-Kelly DA; Tatarnikov I; Khinda J; Volta M; Kadgien C; Cao LP; Tapia L; Klein C; Farrer MJ
Hum Mol Genet; 2015 Mar; 24(6):1691-703. PubMed ID: 25416282
[TBL] [Abstract][Full Text] [Related]
17. Retromer regulates the lysosomal clearance of MAPT/tau.
Carosi JM; Hein LK; van den Hurk M; Adams R; Milky B; Singh S; Bardy C; Denton D; Kumar S; Sargeant TJ
Autophagy; 2021 Sep; 17(9):2217-2237. PubMed ID: 32960680
[TBL] [Abstract][Full Text] [Related]
18. Vps35-deficiency impairs SLC4A11 trafficking and promotes corneal dystrophy.
Liu W; Tang FL; Lin S; Zhao K; Mei L; Ye J; Xiong WC
PLoS One; 2017; 12(9):e0184906. PubMed ID: 28934248
[TBL] [Abstract][Full Text] [Related]
19. Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP.
Jiang M; Tu HT; Zhang K; Zhang W; Yu WP; Xu J; Tan EK; Guo KH; Zeng L
Neurobiol Dis; 2021 Jun; 153():105313. PubMed ID: 33636388
[TBL] [Abstract][Full Text] [Related]
20. Implication of mouse Vps26b-Vps29-Vps35 retromer complex in sortilin trafficking.
Kim E; Lee Y; Lee HJ; Kim JS; Song BS; Huh JW; Lee SR; Kim SU; Kim SH; Hong Y; Shim I; Chang KT
Biochem Biophys Res Commun; 2010 Dec; 403(2):167-71. PubMed ID: 21040701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
